Your browser doesn't support javascript.
loading
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer.
Yi, Jingyan; Liu, Chongya; Tao, Zhiwei; Wang, Min; Jia, Yaxun; Sang, Xiaolin; Shen, Lanlin; Xue, Yijue; Jiang, Kui; Luo, Fuwen; Liu, Pixu; Cheng, Hailing.
Affiliation
  • Yi J; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Liu C; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Tao Z; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Wang M; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Jia Y; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Sang X; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Shen L; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Xue Y; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
  • Jiang K; Department of Oncology, The Second Hospital of Dalian Medical University, Dalian 116044, China.
  • Luo F; Department of Acute Abdomen Surgery, The Second Hospital of Dalian Medical University, Dalian 116044, China.
  • Liu P; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China; College of Pharmacy, Dalian Medical University, Dalian 116044, China. Electronic address: pixu_liu@dmu.edu.cn.
  • Cheng H; Cancer Institute, The Second Hospital of Dalian Medical University, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China. Electronic address: hailingcheng_dmu@163.com.
EBioMedicine ; 43: 225-237, 2019 May.
Article in En | MEDLINE | ID: mdl-30898650
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Phthalazines / Piperazines / Pyridines / Gene Expression Regulation, Neoplastic / Genes, myc / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EBioMedicine Year: 2019 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Phthalazines / Piperazines / Pyridines / Gene Expression Regulation, Neoplastic / Genes, myc / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EBioMedicine Year: 2019 Document type: Article Affiliation country: China